Medtronic launches yet another back pain neurostim study

April 11, 2013 by Arezu Sarvestani

Medical device company Medtronic continues to battle for its position in the market for neurostimulation systems that treat pain with a new clinical study of treatments for chronic back pain.

chronic back pain illustration

Medtech titan Medtronic (NYSE:MDT) enrolled the initial patients in its SubQStim II pivotal clinical trial, evaluating the use of peripheral nerve stimulation in treatment of chronic back pain.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.